ES480921A0 - Un metodo para preparar acido (todo z)-5,8,11,14,17-eicosa- pentaenoico o una sal, ester o amida del mismo farmaceutica-mente aceptable - Google Patents

Un metodo para preparar acido (todo z)-5,8,11,14,17-eicosa- pentaenoico o una sal, ester o amida del mismo farmaceutica-mente aceptable

Info

Publication number
ES480921A0
ES480921A0 ES480921A ES480921A ES480921A0 ES 480921 A0 ES480921 A0 ES 480921A0 ES 480921 A ES480921 A ES 480921A ES 480921 A ES480921 A ES 480921A ES 480921 A0 ES480921 A0 ES 480921A0
Authority
ES
Spain
Prior art keywords
pentaenoic
eicosa
mind
amide
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES480921A
Other languages
English (en)
Other versions
ES8104983A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2357578A external-priority patent/GB1604554A/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES480921A0 publication Critical patent/ES480921A0/es
Publication of ES8104983A1 publication Critical patent/ES8104983A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A23C15/126—Butter containing a minority of vegetable oils; Enrichment of butter with fatty acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES480921A 1978-05-26 1979-05-25 Un metodo para preparar acido (todo z)-5,8,11,14,17-eicosa- pentaenoico o una sal, ester o amida del mismo farmaceutica-mente aceptable Expired ES8104983A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2357478 1978-05-26
GB2357578A GB1604554A (en) 1978-05-26 1978-05-26 Pharmaceutical and food formulations

Publications (2)

Publication Number Publication Date
ES480921A0 true ES480921A0 (es) 1981-05-16
ES8104983A1 ES8104983A1 (es) 1981-05-16

Family

ID=26256599

Family Applications (1)

Application Number Title Priority Date Filing Date
ES480921A Expired ES8104983A1 (es) 1978-05-26 1979-05-25 Un metodo para preparar acido (todo z)-5,8,11,14,17-eicosa- pentaenoico o una sal, ester o amida del mismo farmaceutica-mente aceptable

Country Status (13)

Country Link
JP (1) JPS5515444A (es)
AU (1) AU527784B2 (es)
CA (1) CA1151068A (es)
CH (1) CH644267A5 (es)
DE (1) DE2831507A1 (es)
ES (1) ES8104983A1 (es)
FR (1) FR2426461A1 (es)
IE (1) IE48287B1 (es)
IL (1) IL55227A (es)
IT (1) IT1116505B (es)
NL (1) NL191332C (es)
NZ (1) NZ187908A (es)
SE (1) SE448678B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5735512A (en) * 1980-06-27 1982-02-26 Nippon Oil & Fats Co Ltd Preventive and remedy for thrombosis
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
JPS60132916A (ja) * 1983-12-21 1985-07-16 Nisshin Oil Mills Ltd:The 血栓症予防食品または医薬品
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
JPH0748991B2 (ja) * 1984-08-29 1995-05-31 日本油脂株式会社 経管栄養組成物
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
NL9401743A (nl) * 1994-10-20 1996-06-03 Prospa Bv Zouten van aminoalcoholen en farmaceutische formuleringen die deze bevatten.
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
DE10056351A1 (de) * 2000-11-14 2002-05-29 Weylandt Karsten Henrich Pharmazeutisches Präparat
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
WO2010127103A1 (en) 2009-04-29 2010-11-04 Amarin Pharma, Inc. Stable pharmaceutical composition and methods of using same
AU2010241567B2 (en) 2009-04-29 2013-10-31 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same
US8455472B2 (en) 2009-06-15 2013-06-04 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
KR101798670B1 (ko) 2009-09-23 2017-11-16 아마린 코포레이션 피엘씨 오메가-3 지방산 및 스타틴의 히드록시-유도체를 포함하는 제약 조성물 및 그의 사용 방법
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
EP2800469B1 (en) 2012-01-06 2021-08-25 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
RS61557B1 (sr) 2012-06-29 2021-04-29 Amarin Pharmaceuticals Ie Ltd Postupci za smanjenje rizika od kardiovaskularnog događaja kod pacijenta na terapiji statinom primenom etil estra eikozapentaenske kiseline
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
SG11201505195TA (en) 2013-02-06 2015-08-28 Agency Science Tech & Res Methods For Reducing Aggregate Content In Protein Preparations
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10966951B2 (en) 2017-05-19 2021-04-06 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
WO2020068163A1 (en) 2018-09-24 2020-04-02 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE319677B (es) * 1965-03-27 1970-01-19 Sumitomo Chemical Co
FR2097036A1 (en) * 1970-07-29 1972-03-03 Sopharga Lab Lipids contg fatty acids - for treatment of atheroslerosis
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
JPS6257605A (ja) * 1985-09-05 1987-03-13 Kaizuka Kazutoshi 多元素鉱物からの有効成分抽出方法

Also Published As

Publication number Publication date
IT7947717A0 (it) 1979-01-19
NL191332B (nl) 1995-01-02
NL191332C (nl) 1995-06-01
CA1151068A (en) 1983-08-02
IE48287B1 (en) 1984-11-28
JPS5515444A (en) 1980-02-02
CH644267A5 (en) 1984-07-31
IT1116505B (it) 1986-02-10
AU527784B2 (en) 1983-03-24
DE2831507C2 (es) 1989-07-13
SE448678B (sv) 1987-03-16
AU3808478A (en) 1980-01-17
FR2426461A1 (fr) 1979-12-21
IL55227A0 (en) 1978-09-29
NL7904144A (nl) 1979-11-28
SE7904570L (sv) 1979-11-27
IE791023L (en) 1979-11-26
DE2831507A1 (de) 1979-11-29
IL55227A (en) 1982-12-31
FR2426461B1 (es) 1983-02-11
ES8104983A1 (es) 1981-05-16
NZ187908A (en) 1984-05-31

Similar Documents

Publication Publication Date Title
ES480921A0 (es) Un metodo para preparar acido (todo z)-5,8,11,14,17-eicosa- pentaenoico o una sal, ester o amida del mismo farmaceutica-mente aceptable
IT7925026A0 (it) Nuovi derivati dell'acido 2,4,6-triiodo-isoftalico, metodo per la loro preparazione e mezzi di contrasto che li contengono.
MX6094E (es) Procedimiento para preparar derivados del acido 6 beta-hidroxialquil penicilanico
IT7925027A0 (it) Derivati dell'acido 2,4,6-triiodo-isoftalico, metodo per la loro preparazione e mezzi di contrasto che li contengono.
MX7115E (es) Procedimiento microbiologico para preparar acido 2,5-diceto-d-gluconico o una sal del mismo
EP0053321A3 (en) Substituted derivatives of phenoxy cinnamic acid, process for their preparation, their use as herbicides, intermediates and the preparation thereof
IT1113036B (it) Procedimento per preparare pastiglie contenenti acido 1,4-diidro-1-etil-6-fluoro-4-osso-7-(1-piperazino)chinolin-3-carbossilico
KR840004667A (ko) 3,7,11,15-테트라메틸-2,4,6,10,14-헥사데카펜타엔산의 제조방법
AR223663A1 (es) Procedimiento para la preparacion de derivados 1,6-disustituidos de acido 4-piridon-3-carboxilico
ES507942A0 (es) Un procedimiento para preparar derivados del acido 7-acilaminocefalosporanico .
ES481233A0 (es) Un procedimiento para la preparacion de derivados del acido 4,5-dihidro-4-oxofuran-2-carboxilico
ES513993A0 (es) "un procedimiento para preparar esteres de acido 3-metilflavon-8-carboxilico".
ES516632A0 (es) "un proceso para la preparacion de derivados de n-alquilimidazoles sustituidos".
RO77772A (ro) Procedeu pentru prepararea unor derivati de acizi 2,2-dimetilciclo‡ropancarboxilici
IT7924631A0 (it) Ammidi dell'acido 1,2,3-triazolcarbossilico, procedimento per preparare questi composti nonche' mezzi biocidi cheli contengono.
ES480265A0 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo (3,2,0) hept-2-en-2-carboxilico
ES513706A0 (es) "procedimiento para preparar esteres de acido n-alcohil-n,n' ,n' -polioxialcohil- diaminoalcohilen-graso".
IL59760A (en) Method for the preparation of 7-oxo-4-thia-1-aza-bicyclo(3,2,0)-heptane-2-carboxylic acid derivatives
RO78492A (ro) Procedeu pentru prepararea unor derivati ai acizilor 1,3,4-tiadiazoli-2-carboxilici
ES508346A0 (es) Un procedimiento para la preparacion de derivados del acido 2 beta-clorometil-2 alfa-metilpenam-3 alfa-carboxilico.
ES516059A0 (es) "un procedimiento para preparar esteres de acido antranilico".
DE2963073D1 (en) Process for preparing amine salts of acid o,s-dialkylthiophosphoric esters
AR224028A1 (es) Un procedimiento para la produccion de acido 2,5-diceto-gluconico
ES511759A0 (es) Procedimiento para preparar derivados del acido 1,4-tiazan-3-carboxilico.
IT7921809A0 (it) Metodo per la produzione di derivati dell'acido 6-beta-amidino-penicillanico.